ライフサイエンスコーパス: endocrinopathy

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 the setting of spotty skin pigmentation and endocrinopathy.

2 ted with spotty pigmentation of the skin and endocrinopathy.

3 isfolding of exportable proteins can trigger endocrinopathies.

4 ated by bilateral involvement and associated endocrinopathies.

5 zed by medullary thyroid carcinoma and other endocrinopathies.

6 , but at higher incidences in particular for endocrinopathies.

7 age, gender, and the occurrence of systemic endocrinopathies also influence sulfotransferase gene ex

8 e of the sulfotransferases in the genesis of endocrinopathies and cancer in humans.

9 pes, which also increase risk for autoimmune endocrinopathies and other autoimmune disorders, encode

10 ontribute to the most common human pituitary endocrinopathies and tumors.

11 gery, the medical treatment specifically for endocrinopathies, and finally, radiation treatments incl

12 malignant neoplasms, cardiovascular disease, endocrinopathies, and neurocognitive impairment.

13 on irAEs including rash, colitis, hepatitis, endocrinopathies, and pneumonitis have been established.

14 nt reduction in IQ and cognitive impairment, endocrinopathy, and risk of second malignancy.

15 The endocrinopathies are a group of illnesses that either pr

16 Endocrinopathies are significant consequences of childho

17 only treatment that can prevent or cure the endocrinopathies associated with multiple endocrine neop

18 Clustering of autoimmune endocrinopathies can result from polygenic predispositio

19 the most commonly encountered perioperative endocrinopathy, continues to increase dramatically in pr

20 ome characterized by autoimmune enteropathy, endocrinopathy, dermatitis, and other autoimmune phenome

21 disease, organomegaly (or lymphadenopathy), endocrinopathy, edema (peripheral edema, ascites, or eff

22 No recurrence of endocrinopathy has been documented at a mean follow-up o

23 sprue in asymptomatic patients, and multiple endocrinopathies in individuals with type 2 disease may

24 e pathogenesis of the more common autoimmune endocrinopathies in our population.

25 Endocrinopathies in survivors increased substantially ov

26 The development of endocrinopathies in survivors of childhood cancer as the

27 ullary thyroid carcinoma (MTC), the dominant endocrinopathy in patients with these hereditary syndrom

28 nic kidney disease (CKD), colorectal cancer, endocrinopathies (including type 2 diabetes mellitus [T2

29 PHPT is a complex endocrinopathy involving calcium metabolism and a potent

30 ed to refer to polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) remains poo

31 lyradiculoneuropathy, organomegaly, multiple endocrinopathies, monoclonal protein, skin changes) is a

32 ally including coexisting Castleman disease, endocrinopathy, monoclonal plasma cell neoplasm, and ski

33 mmon features: Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes) is

34 aracterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes.

35 including non-convulsive status epilepticus, endocrinopathy, or thiamine deficiency.

36 s undergoing CSI were more likely to develop endocrinopathies (P < .0001) and to require special educ

37 c findings of MAS including hyperfunctioning endocrinopathies, polyostotic fibrous dysplasia, and caf

38 al plasma cell disorder (PCD), organomegaly, endocrinopathy, skin changes, edema, sclerotic bone lesi

39 nimal operative morbidity and eradication of endocrinopathy support the minimally invasive approach f

40 neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome (IPEX; MIM 304930) is the geneti

41 We identified a pattern of endocrinopathies that develop in an age-dependent manner

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。